Mr. Speaker, our government is a large spender on pharmaceutical benefits, providing approximately $600 million last year to cover pharmaceutical products and medical supplies. This funding is a positive investment for a diverse population. As well, we have continued to honour our 2004 health accord, which provides $41.3 billion in additional funding to the provinces and territories.
Our government agreed to a shared agenda with the provinces and territories to improve our collective management of pharmaceuticals, recognizing our complementary roles in this sector.